Business Standard

Sunday, December 22, 2024 | 06:50 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Serum hopes to launch Novavax Covid vaccine for children in 6 months: CEO

The vaccine, called Covovax, has shown good results in trials in children aged three and older.

Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India
Premium

Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India (Photo: PTI image)

Reuters New Delhi
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.

The vaccine, which SII calls Covovax, has shown good results in trials in children aged three and older, Adar Poonawalla told an industry conference.

Disclaimer: No Business Standard Journalist was involved in creation of this content

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in